EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amyloid-β, Tau, and α-Synuclein Protein Interactomes as Therapeutic Targets in Neurodegenerative Diseases

D Mohan Kumar, Priti Talwar

Cellular and Molecular Neurobiology · 06.10.2025 · 45 (1)

DOI: 10.1007/s10571-025-01604-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Neurobiology, online erschienen am 06.10.2025. Verfasst von D Mohan Kumar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Apoptosis and Cell Survival Research Laboratory, 412G Pearl Research Park, Department of Biosciences, School of Biosciences and Technology, Vellore I…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, tau Proteins, alpha-Synuclein, Proteome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vellore Institute of Technology, Vellore, India, Vellore Institute of Technology, Vellore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s and Parkinson’s disease are the most prevalent neurological diseases. Amyloid-β, tau, and α-synuclein proteins are known to be implicated in neurodegenerative disease (NDD). Elucidation of precise therapeutic targets remains a challenge. Therefore, the identification of interactomes of amyloid-β precursor protein (APP), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) proteins is of great interest, aimed at unraveling novel targets. An integrated analysis was employed to identify direct interactors as therapeutic targets, considering protein–protein interactions and subsequent network analysis. Further, it was proposed to identify hub proteins, intended targets, regulatory factors, disease-gene associations, functional enrichment analyses of the protein interactors interfered with gene ontologies and disease-driving pathways. Protein interactome centered on APP, MAPT, and SNCA identified the top hundred high-confidence protein–protein interactions that revealed BACE1, PSEN1, SORL1, GSK3B, CDK5, SNCAIP, PRKN, and APOE as physical and functional protein interactors. The top ten hub proteins were ranked based on multiple centrality measures and topological algorithms. Further, the integrated network of all three protein interactomes contained distinct nodes with edges. Interestingly, regulatory mechanisms have revealed possible regulatory modules, including cleavage, phosphorylation, and ubiquitination. Top interacting proteins were enriched in several ontology terms, such as regulation of neuronal apoptotic processes, amyloid beta fibril formation, and tau protein binding. Pathway analysis mapped the pathways of neurodegeneration-multiple disease, with a significant level of interacting proteins. Finally, the most comprehensive interactome associated with NDD provides insights into protein interactors, regulating the mechanisms of key proteins that can serve as novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-Peptidestau Proteinsalpha-SynucleinProteomeNeurodegenerative DiseasesHumansProtein Interaction MapsProtein Binding

Stichwörter der Autor:innen

Amyloid-βProtein interactomesTau proteinTherapeutic targetsα-synuclein

Substanzen

Amyloid beta-Peptidestau Proteinsalpha-SynucleinProteome

Autor:innen und Institutionen

  • Apoptosis and Cell Survival Research Laboratory, 412G Pearl Research Park, Department of Biosciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
  • Apoptosis and Cell Survival Research Laboratory, 412G Pearl Research Park, Department of Biosciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. priti.t@vi…

Förderung

  • Vellore Institute of Technology, Vellore, India
  • Vellore Institute of Technology, Vellore

Zitieren

APA

Mohan Kumar, D., & Talwar, P. (2025). Amyloid-β, Tau, and α-Synuclein Protein Interactomes as Therapeutic Targets in Neurodegenerative Diseases. Cellular and Molecular Neurobiology, 45(1). https://doi.org/10.1007/s10571-025-01604-7

Vancouver

Mohan Kumar D, Talwar P. Amyloid-β, Tau, and α-Synuclein Protein Interactomes as Therapeutic Targets in Neurodegenerative Diseases. Cellular and Molecular Neurobiology. 2025;45(1). doi:10.1007/s10571-025-01604-7

BibTeX
@article{MohanKumar2025,
  author = {Mohan Kumar, D and Talwar, Priti},
  title = {Amyloid-β, Tau, and α-Synuclein Protein Interactomes as Therapeutic Targets in Neurodegenerative Diseases},
  journal = {Cellular and Molecular Neurobiology},
  year = {2025},
  volume = {45},
  number = {1},
  doi = {10.1007/s10571-025-01604-7}
}
Kostenlos starten →